World Health Organization Raises Warning Over Critical Scarcity of Weight-Loss Medications

Under 10% of individuals who could benefit from weight-loss injections such as Wegovy are able to get them, caution the World Health Organization as it releases its initial guidance on the therapies.

Considering over a billion people worldwide currently classified as obese, it is calling for increased and just access to this class of drugs.

Based on forecasts, more than two billion will be living with obesity by 2030 without intervention.

"Our new guidelines acknowledges that excess weight is a long-term condition that can be managed with holistic and lifelong care," remarked WHO director-general Tedros Adhanom Ghebreyesus.

Significant expense, constrained manufacturing, and logistical bottlenecks are significant obstacles to universal availability to the jabs that can assist patients in reducing substantial body mass, explains the body.

Skinny Jab Shortage

Even in the present most favorable scenario, the manufacturing of these medications might only reach approximately 100 million people – less than 10% of those who need them, as stated by the WHO.

The advice urges nations and manufacturers to widen access, through approaches such as voluntary licensing.

A patent on the active ingredient – the main ingredient of the drug Wegovy – is set to lapse in multiple countries in 2026.

How Weight-Loss Jabs Work

These medications replicate a biological compound to slow digestion, curb appetite and boost the sense of being full so individuals consume fewer calories.

Individuals typically start to lose weight after several weeks of commencing the once-weekly jabs.

Studies suggests people may see weight return after a year of stopping the medication, when their normal hunger come back.

To be carrying excess weight elevates your risk for contracting medical conditions, such as diabetes, heart disease, brain attack, and certain malignancies.

Obesity impacts people in every country and was associated with 3.7 million fatalities worldwide in 2024, as per the WHO.